Respiratory Distress Syndrome in Preterm Infants
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome in Preterm Infants.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-02-10FDA Approved: SURVANTA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for SURVANTA (beractant) by AbbVie, authorizing changes to its labeling and/or indications.